Kirkwood JM - Search Results

1

Downstream consequences of melanoma screening in a community practice setting: First results.

Weinstock MA, Ferris LK, Saul MI, Geller AC, Risica PM, Siegel JA, Solano FX, Kirkwood JM. Weinstock MA, et al. Among authors: kirkwood jm. Cancer. 2016 Oct 15;122(20):3152-3156. doi: 10.1002/cncr.30177. Epub 2016 Jul 8. Cancer. 2016. PMID: 27391802 Free PMC article.

2

Interstitial hypertension in superficial metastatic melanomas in humans.

Boucher Y, Kirkwood JM, Opacic D, Desantis M, Jain RK. Boucher Y, et al. Among authors: kirkwood jm. Cancer Res. 1991 Dec 15;51(24):6691-4. Cancer Res. 1991. PMID: 1742743

3

Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI.

Roush GC, Barnhill RL, Ernstoff MS, Kirkwood JM. Roush GC, et al. Among authors: kirkwood jm. Br J Cancer. 1991 Aug;64(2):373-6. doi: 10.1038/bjc.1991.310. Br J Cancer. 1991. PMID: 1892767 Free PMC article.

4

Dysplastic nevi in association with multiple primary melanoma.

Titus-Ernstoff L, Duray PH, Ernstoff MS, Barnhill RL, Horn PL, Kirkwood JM. Titus-Ernstoff L, et al. Among authors: kirkwood jm. Cancer Res. 1988 Feb 15;48(4):1016-8. Cancer Res. 1988. PMID: 3338073

5

Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.

Posner MC, Lienard D, Lejeune FJ, Rosenfelder D, Kirkwood J. Posner MC, et al. Cancer J Sci Am. 1995 Nov-Dec;1(4):274-80. Cancer J Sci Am. 1995. PMID: 9166488

6

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.

Agarwala SS, Ferri W, Gooding W, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Cancer. 1999 May 1;85(9):1979-84. Cancer. 1999. PMID: 10223239 Clinical Trial.

7

Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.

Kirkwood JM, Mascari RA, Edington HD, Rabkin MS, Day RS, Whiteside TL, Vlock DR, Shipe-Spotloe JM. Kirkwood JM, et al. Cancer. 2000 Jun 15;88(12):2693-702. Cancer. 2000. PMID: 10870051 Clinical Trial.

8

Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690.

Kirkwood JM, Richards T, Zarour HM, Sosman J, Ernstoff M, Whiteside TL, Ibrahim J, Blum R, Wieand S, Mascari R. Kirkwood JM, et al. Cancer. 2002 Sep 1;95(5):1101-12. doi: 10.1002/cncr.10775. Cancer. 2002. PMID: 12209697 Free article. Clinical Trial.

9

Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Cancer. 2003 Jan 1;97(1):121-7. doi: 10.1002/cncr.11041. Cancer. 2003. PMID: 12491513 Free article. Clinical Trial.

10

Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.

Agarwala SS, Neuberg D, Park Y, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Cancer. 2004 Apr 15;100(8):1692-8. doi: 10.1002/cncr.20166. Cancer. 2004. PMID: 15073858 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

610 results

Search Page

Filters